WCJB43 分钟
University of Florida lab uses fungi to help address the challenges of treating brain disorders
Dr. Jamal Lewis’s lab is trying to repurpose a fungus to shuttle pharmaceuticals to the central nervous system and treat ...
Managed Healthcare Executive3 小时
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Additional Treatment for Depression
The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
Title: Randomized, Double-Blind Study of BNC210, a Negative Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor, in Posttraumatic Stress Disorder (PTSD): The Attune Trial Presenter: Murray ...
BioSpace9 小时
Intra-Cellular Eyes Depression Approval for Caplyta as Stock Soars Under the Radar
Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...
Praxis Precision Medicines to Present at Upcoming December Investor Conferences
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...